Share on LinkedInShare on LinkedIn

ARTICLE · 13 FEBRUARY 2023

To Share Or Not To Share: DOJ Withdraws Information Sharing Guidance

WilmerHale
WilmerHale
Contributor
WilmerHale

WilmerHale

WilmerHale's London office was established more than 40 years ago. With lawyers qualified in the...

View firm profile
Explore more from WilmerHale

The Department of Justice (DOJ) Antitrust Division recently withdrew three sets of policy statements regarding the US antitrust agencies' enforcement approach to conduct in the healthcare industry...

United StatesAntitrust/Competition Law

The Department of Justice (DOJ) Antitrust Division recently withdrew three sets of policy statements regarding the US antitrust agencies' enforcement approach to conduct in the healthcare industry that may have broader implications for treatment of information sharing agreements under US antitrust law. The policy statements included a safety zone framework for sharing competitively sensitive information without risk of antitrust liability that the agencies have extended beyond healthcare sectors.

DOJ's withdrawal statement, and a contemporaneous speech by the Principal Deputy Assistant Attorney General of DOJ's Antitrust Division, Doha Mekki, highlight concerns about the guidance on exchange of nonpublic information among competitors. With the withdrawal, information sharing arrangements both inside and outside of the healthcare industry may be subject to increased government scrutiny. Companies that have shared or are continuing to share industry information based

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from